4//SEC Filing
Waters Kevin 4
Accession 0001628280-24-043032
CIK 0001588978other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:27 PM ET
Size
12.6 KB
Accession
0001628280-24-043032
Insider Transaction Report
Form 4
Waters Kevin
EVP, CFO
Transactions
- Exercise/Conversion
Common Stock
2024-10-15$4.56/sh+25,000$114,000→ 121,096 total - Sale
Common Stock
2024-10-15$72.11/sh−15,959$1,150,803→ 105,137 total - Sale
Common Stock
2024-10-15$73.02/sh−8,115$592,557→ 97,022 total - Sale
Common Stock
2024-10-15$73.75/sh−926$68,293→ 96,096 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-15−25,000→ 19,160 totalExercise: $4.56Exp: 2029-12-11→ Common Stock (25,000 underlying)
Footnotes (5)
- [F1]The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.56 to $72.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.56 to $73.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.56 to $73.87. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F5]The stock option was granted on December 12, 2019 and vested over a four year period.
Documents
Issuer
PROCEPT BioRobotics Corp
CIK 0001588978
Entity typeother
Related Parties
1- filerCIK 0001653771
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:27 PM ET
- Size
- 12.6 KB